Skye Bioscience, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.14-$5.96 |
Market Cap | $123.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.06 |
News
See moreYahoo Finance • 4 days ago
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
Yahoo Finance • 18 days ago
PIMCO Intermediate Municipal Bond Exchange-Traded Fund (MUNI) Shares Cross Above 200 DMA
Yahoo Finance • 27 days ago
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
Yahoo Finance • last month
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
About
CEO | Mr. Punit S. Dhillon B.A. |
Address | 11250 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 16 |
